Given that the primary tumor expression did not correlate well with that of the metastases, and knowing that systemic therapy is used to treat metastatic disease, collectively these data and our findings suggest that correlative biomarker analyses for c-Met should utilize metastatic tissue sites. Here, MET is linked to neoplasm.